We are live on ! Find out more
NSPRZ

InspireMD, Inc. Series B Warrants

Delisted

NSPRZ was delisted on the 14th of March, 2022.

2 hedge funds and large institutions have $16K invested in InspireMD, Inc. Series B Warrants in 2021 Q2 according to their latest regulatory filings, with funds opening new positions, 1 increasing their positions, 1 reducing their positions, and 2 closing their positions.

New
Increased
Maintained
Reduced
Closed

0% more repeat investments, than reductions

Existing positions increased: 1 | Existing positions reduced: 1

11% less capital invested

Capital invested by funds: $18K → $16K (-$2K)

50% less funds holding

Funds holding: 42 (-2)

100% less first-time investments, than exits

New positions opened: 0 | Existing positions closed: 2

Holders
2
Holders Change
-2
Holders Change %
-50%
% of All Funds
0.03%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
1
Reduced
1
Closed
2
Calls
Puts
Net Calls
Net Calls Change
Name Holding Trade Value Shares
Change
Change in
Stake
VF
1
Virtu Financial
New York
$9K +$1.64K +24,681 +105%
UBS Group
2
UBS Group
Switzerland
$7K -$5.66K -85,341 -70%
Susquehanna International Group
3
Susquehanna International Group
Pennsylvania
-$10K -244,335 Closed
Citadel Advisors
4
Citadel Advisors
Florida
-$2K -40,919 Closed

NSPRZ Hedge Fund Activity: Q2 2021 in Review

2 of the 5,746 institutional investors tracked by Wall St. Rank reported a position in InspireMD, Inc. Series B Warrants (NSPRZ) for Q2 2021, worth a combined $16K — down 11% from $18K a quarter earlier.

Sellers outnumbered buyers: 2 funds closed out of NSPRZ and 0 opened new positions — a net loss of 2 holders — while 1 trimmed existing stakes and 1 added.

The largest buyer was Virtu Financial, adding an estimated $1.64K. The largest seller was Susquehanna International Group, exiting entirely with an estimated $10K sold.

  • 2 institutional investors held InspireMD, Inc. Series B Warrants (NSPRZ) as of Q2 2021, down from 4 in Q1 2021.
  • Funds reported $16K of InspireMD, Inc. Series B Warrants stock for Q2 2021, down 11% quarter-over-quarter.
  • 0 funds opened new InspireMD, Inc. Series B Warrants positions in Q2 2021 and 2 closed out, a net change of -2 holders.
  • The largest InspireMD, Inc. Series B Warrants buyer in Q2 2021 was Virtu Financial, an estimated $1.64K added.
  • The largest InspireMD, Inc. Series B Warrants seller in Q2 2021 was Susquehanna International Group, an estimated $10K sold.

Based on aggregated 13F filings for Q2 2021.